Your web browser may be malfunctioning. Ada guidelines 2012 pdf internet connection may be unreliable. 2014 by the American Diabetes Association and Springer-Verlag. Copying with attribution allowed for any noncommercial use of the work.
This was needed because of an increasing array of antihyperglycemic drugs and growing uncertainty regarding their proper selection and sequence. Because of a paucity of comparative effectiveness research on long-term treatment outcomes with many of these medications, the 2012 publication was less prescriptive than prior consensus reports. We previously described the need to individualize both treatment targets and treatment strategies, with an emphasis on patient-centered care and shared decision making, and this continues to be our position, although there are now more head-to-head trials that show slight variance between agents with regard to glucose-lowering effects. Nevertheless, these differences are often small and would be unlikely to reflect any definite differential effect in an individual patient.
The ADA and EASD have requested an update to the position statement incorporating new data from recent clinical trials. Between June and September of 2014, the Writing Group reconvened, including one face-to-face meeting, to discuss the changes. An entirely new statement was felt to be unnecessary. Instead, the group focused on those areas where revisions were suggested by a changing evidence base. Glucose control remains a major focus in the management of patients with type 2 diabetes.
However, this should always be in the context of a comprehensive cardiovascular risk factor reduction program, to include smoking cessation and the adoption of other healthy lifestyle habits, blood pressure control, lipid management with priority to statin medications, and, in some circumstances, antiplatelet therapy. 11Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, U. Oxford Biomedical Research Centre, Oxford, U. 13Harris Manchester College, University of Oxford, Oxford, U. Management of hyperglycemia in type 2 diabetes: a patient-centered approach.